# Giovanni Sotgiu

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/giovanni-sotgiu/

## Facts

| Field | Value |
| --- | --- |
| Citations | 30,626 |
| Field | Tuberculosis Research and Epidemiology |
| h-index | 85 |
| i10-index | 398 |
| Last Known Institution | University of Sassari |
| OpenAlex ID | https://openalex.org/A5071827015 |
| ORCID iD | 0000-0002-1600-4474 |
| Works | 888 |

## Researcher papers

Showing 12 of 20.

- [Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis](https://scholariq.org/papers/official-american-thoracic-society-centers-for-disease-control-and-prevention/)
- [Towards tuberculosis elimination: an action framework for low-incidence countries](https://scholariq.org/papers/towards-tuberculosis-elimination-an-action-framework-for-low-incidence-countries/)
- [Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals](https://scholariq.org/papers/control-of-confounding-and-reporting-of-results-in-causal-inference-studies/)
- [Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis](https://scholariq.org/papers/treatment-correlates-of-successful-outcomes-in-pulmonary-multidrug-resistant/)
- [Management of latent<i>Mycobacterium tuberculosis</i>infection: WHO guidelines for low tuberculosis burden countries](https://scholariq.org/papers/management-of-latent-i-mycobacterium-tuberculosis-i-infection-who-guidelines-for/)
- [Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis](https://scholariq.org/papers/best-drug-treatment-for-multidrug-resistant-and-extensively-drug-resistant/)
- [Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis](https://scholariq.org/papers/interferon-release-assays-for-the-diagnosis-of-active-tuberculosis-a-systematic/)
- [Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients](https://scholariq.org/papers/multidrug-resistant-pulmonary-tuberculosis-treatment-regimens-and-patient/)
- [The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement](https://scholariq.org/papers/the-risk-of-tuberculosis-related-to-tumour-necrosis-factor-antagonist-therapies/)
- [Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline](https://scholariq.org/papers/treatment-of-drug-resistant-tuberculosis-an-official-ats-cdc-ers-idsa-clinical/)
- [The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis](https://scholariq.org/papers/the-risk-of-tuberculosis-in-children-after-close-exposure-a-systematic-review/)
- [Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study](https://scholariq.org/papers/effectiveness-and-safety-of-bedaquiline-containing-regimens-in-the-treatment-of/)

## Researcher topics

- [Tuberculosis Research and Epidemiology](https://scholariq.org/topics/tuberculosis-research-and-epidemiology/)
- [Infectious Diseases and Tuberculosis](https://scholariq.org/topics/infectious-diseases-and-tuberculosis/)
- [Diagnosis and treatment of tuberculosis](https://scholariq.org/topics/diagnosis-and-treatment-of-tuberculosis/)
- [Pneumonia and Respiratory Infections](https://scholariq.org/topics/pneumonia-and-respiratory-infections/)
- [Mycobacterium research and diagnosis](https://scholariq.org/topics/mycobacterium-research-and-diagnosis/)

## Researcher university

- [University of Sassari](https://scholariq.org/institutions/university-of-sassari/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.